Literature DB >> 96726

Activity of azlocillin and mezlocillin against gram-negative organisms: comparison with other penicillins.

R Wise, A P Gillett, J M Andrews, K A Bedford.   

Abstract

The activities of azlocillin and mezlocillin were compared with those of carbenicillin, ticarcillin, and pirbenicillin against a wide range of gram-negative organisms. The two new drugs were considerably more active than carbenicillin against Klebsiella species and Escherichia coli. Carbenicillin was twice as active against Proteus mirabilis as mezlocillin and four times as active as azlocillin. Against Pseudomonas aeruginosa, azlocillin was eight times as active as carbenicillin. Azlocillin and mezlocillin were twice as active as carbenicillin against Bacteroides fragilis, and these drugs showed a high degree of activity against Haemophilus influenzae and Neisseria gonorrhoeae.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 96726      PMCID: PMC352288          DOI: 10.1128/AAC.13.4.559

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  11 in total

1.  Carbenicillin-induced coagulopathy.

Authors:  A Lurie; M Ogilvie; R Townsend; C Gold; A M Meyers; B Goldberg
Journal:  Lancet       Date:  1970-05-23       Impact factor: 79.321

2.  Carbenicillin and hypokalemia.

Authors:  J Klastersky; B Vanderklen; D Daneau; M Mathiew
Journal:  Ann Intern Med       Date:  1973-05       Impact factor: 25.391

3.  Carbenicillin: a new semisynthetic penicillin active against Pseudomonas pyocyanea.

Authors:  E T Knudsen; G N Rolinson; R Sutherland
Journal:  Br Med J       Date:  1967-07-08

4.  Mezlocillin: in vitro studies of a new broad-spectrum penicillin.

Authors:  G P Bodey; T Pan
Journal:  Antimicrob Agents Chemother       Date:  1977-01       Impact factor: 5.191

5.  Clinical evaluation of carbenicillin in the treatment of infection due to anaerobic bacteria.

Authors:  W Fiedelman; C D Webb
Journal:  Curr Ther Res Clin Exp       Date:  1975-09

6.  Pirbenicillin--a semi-synthetic penicillin with antipseudomonal activity.

Authors:  R Wise; J M Andrews; K A Bedford
Journal:  J Antimicrob Chemother       Date:  1977-03       Impact factor: 5.790

7.  Azlocillin: in vitro studies of a new semisynthetic penicillin.

Authors:  D Stewart; G P Bodey
Journal:  Antimicrob Agents Chemother       Date:  1977-05       Impact factor: 5.191

8.  Pirbenicillin, a new semisynthetic penicillin with broad-spectrum activity.

Authors:  G P Bodey; V Rodriguez; S Weaver
Journal:  Antimicrob Agents Chemother       Date:  1976-04       Impact factor: 5.191

9.  Novel method for detection of beta-lactamases by using a chromogenic cephalosporin substrate.

Authors:  C H O'Callaghan; A Morris; S M Kirby; A H Shingler
Journal:  Antimicrob Agents Chemother       Date:  1972-04       Impact factor: 5.191

10.  BL-P1654: a bacteriostatic penicillin?

Authors:  C C Sanders; W E Sanders
Journal:  Antimicrob Agents Chemother       Date:  1975-04       Impact factor: 5.191

View more
  26 in total

1.  Pharmacokinetic comparison of 5 g of azlocillin every 8 h and 4 g every 6 h in healthy volunteers.

Authors:  R D Lander; R P Henderson; D R Pyszczynski
Journal:  Antimicrob Agents Chemother       Date:  1989-05       Impact factor: 5.191

2.  Pharmacokinetics of Bay k 4999, a new broad-spectrum penicillin.

Authors:  R Wise; B Cadge; A P Gillett; A Bhamjee; R Livingston; P G Welling; D P Thornhill
Journal:  Antimicrob Agents Chemother       Date:  1979-05       Impact factor: 5.191

3.  Elimination of azlocillin in patients with biliary t-tube drainage.

Authors:  U Gundert-Remy; E Weber
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

4.  [Concentrations of mezlocillin in cerebrospinal fluid in vira meningitis (author's transl)].

Authors:  H G Hoffmann; D Förster; I Schoen
Journal:  Infection       Date:  1980       Impact factor: 3.553

5.  HR 756, a highly active cephalosporin: comparison with cefazolin and carbenicillin.

Authors:  R Wise; T Rollason; M Logan; J M Andrews; K A Bedford
Journal:  Antimicrob Agents Chemother       Date:  1978-12       Impact factor: 5.191

6.  Azlocillin compared with carbenicillin in the treatment of bronchopulmonary infection due to Pseudomonas aeruginosa in cystic fibrosis.

Authors:  A Penketh; M E Hodson; H Gaya; J C Batten
Journal:  Thorax       Date:  1984-04       Impact factor: 9.139

7.  Comparison of the activities of the new ureidopenicillins piperacillin, mezlocillin, azlocillin, and Bay k 4999 against gram-negative organisms.

Authors:  L Verbist
Journal:  Antimicrob Agents Chemother       Date:  1979-08       Impact factor: 5.191

8.  [Azlocillin--a new anti-pseudomonas penicillin. A review of the literature and pharmacokinetic studies].

Authors:  Z Modr; K Dvorácek; I Janků; V Krebs
Journal:  Infection       Date:  1982       Impact factor: 3.553

9.  In vitro and in vivo studies of three antibiotic combinations against gram-negative bacteria and Staphylococcus aureus.

Authors:  S H Zinner; J Klastersky; H Gaya; C Bernard; J C Ryff
Journal:  Antimicrob Agents Chemother       Date:  1981-10       Impact factor: 5.191

10.  Statistical comparison of the antibacterial activities of broad-spectrum penicillins against gram-negative bacilli.

Authors:  R J Fass
Journal:  Antimicrob Agents Chemother       Date:  1983-08       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.